Abbott Laboratories
NYSE:ABT Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 221 Fair Values set on narratives written by author
WA
Consensus Narrative from 24 Analysts
Leadless Pacemakers And Glucose Monitoring Expansion Signal Positive Future
Key Takeaways Abbott's focus on innovation and high-growth markets aims to drive strong revenue growth and market share improvement. Margin expansion and product mix improvements are expected to enhance net margins and support earnings growth potential.
View narrativeUS$130.62
FV
0.3% undervalued intrinsic discount6.96%
Revenue growth p.a.
3users have liked this narrative
0users have commented on this narrative
28users have followed this narrative
28 days ago author updated this narrative